Sei Investments CO Eagle Pharmaceuticals, Inc. Transaction History

Sei Investments CO

$66.7 Billion
Q1 2024

A detailed history of Sei Investments CO transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Sei Investments CO holds 10,134 shares of EGRX stock, worth $53,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,134

Previous 61,574 83.54%

Holding current value

$53,000

Previous $322,000 83.54%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$4.26 - $6.51 $219,134 - $334,874	-51,440 Reduced 83.54%	10,134 $53,000
Q3 2023 Nov 14, 2023	SELL	$15.21 - $22.88 $128,341 - $193,061	-8,438 Reduced 12.05%	61,574 $971,000
Q1 2023 May 12, 2023	SELL	$25.06 - $34.09 $77,836 - $105,883	-3,106 Reduced 4.25%	70,012 $1.99 Million
Q4 2022 Feb 10, 2023	SELL	$24.98 - $39.77 $34,722 - $55,280	-1,390 Reduced 1.87%	73,118 $2.14 Million
Q3 2022 Nov 14, 2022	BUY	$26.42 - $47.12 $911,331 - $1.63 Million	34,494 Added 86.2%	74,508 $1.97 Million

Q2 2022 Aug 15, 2022	BUY	$41.26 - $51.35 $725,887 - $903,400	17,593 Added 78.47%	40,014 $1.78 Million
Q1 2022 May 13, 2022	BUY	$44.58 - $52.6 $772,437 - $911,400	17,327 Added 340.15%	22,421 $1.11 Million
Q4 2021 Feb 14, 2022	SELL	$45.82 - $56.9 $64,010 - $79,489	-1,397 Reduced 21.52%	5,094 $259,000
Q3 2021 Nov 12, 2021	BUY	$43.79 - $55.78 $284,240 - $362,067	6,491 New	6,491 $347,000
Q4 2020 Feb 08, 2021	SELL	$41.72 - $51.34 $344,774 - $424,273	-8,264 Closed	0 $0
Q3 2020 Dec 04, 2020	SELL	$37.02 - $51.28 $925 - $1,282	-25 Reduced 0.3%	8,264 $323,000
Q3 2020 Nov 06, 2020	BUY	$37.02 - $51.28 $66,821 - $92,560	1,805 Added 27.84%	8,289 $324,000
Q2 2020 Aug 17, 2020	SELL	$43.24 - $55.02 $245,516 - $312,403	-5,678 Reduced 46.69%	6,484 $311,000
Q2 2020 Aug 11, 2020	BUY	$43.24 - $55.02 $220,826 - $280,987	5,107 Added 72.39%	12,162 $731,000
Q1 2020 May 14, 2020	SELL	$34.37 - $60.07 $175,527 - $306,777	-5,107 Reduced 41.99%	7,055 $325,000
Q4 2019 Feb 06, 2020	SELL	$54.32 - $64.31 $69,203 - $81,930	-1,274 Reduced 9.48%	12,162 $731,000
Q3 2019 Nov 12, 2019	BUY	$53.25 - $59.98 $118,747 - $133,755	2,230 Added 19.9%	13,436 $760,000
Q2 2019 Aug 14, 2019	BUY	$46.61 - $58.45 $465,400 - $583,623	9,985 Added 817.77%	11,206 $624,000
Q1 2019 May 15, 2019	SELL	$38.66 - $51.82 $4.51 Million - $6.04 Million	-116,581 Reduced 98.96%	1,221 $62,000
Q3 2018 Nov 08, 2018	BUY	$66.65 - $83.86 $368,107 - $463,158	5,523 Added 4.92%	117,802 $8.17 Million
Q2 2018 Aug 03, 2018	BUY	$51.25 - $76.62 $4.05 Million - $6.05 Million	78,953 Added 236.91%	112,279 $8.5 Million
Q1 2018 May 11, 2018	BUY	$52.16 - $66.86 $23,993 - $30,755	460 Added 1.4%	33,326 $1.76 Million
Q4 2017 Feb 08, 2018	BUY	$49.6 - $60.87 $299,980 - $368,141	6,048 Added 22.55%	32,866 $1.76 Million
Q3 2017 Nov 06, 2017	BUY	$46.62 - $60.36 $1.25 Million - $1.62 Million	26,818	26,818 $1.6 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

10.4M

Call Options Held

Put Options Held

36.3K

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $68.1M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Eagle Pharmaceuticals, Inc. Transaction History